Batch Numbering. Bachem shall implement and use a unique batch numbering system for numbering each batch of Product. This number shall appear on all documents relating to the particular batch of Product. Bachem is responsible for maintaining an associated lot genealogy, where the final lot number may be traced back to the intermediates and starting materials used in the specified batch.
Batch Numbering. Sanofi or its subcontractor shall assign to each batch of Bulk Substance a unique batch number according to their current approved batch numbering and naming conventions. This number shall appear on all documents relating to the particular batch of Bulk Substance and the format of this number will be provided to KaloBios on request. For Bulk Substance Manufactured by Sanofi’s subcontractor, Sanofi may need to assign its own unique batch number for the purpose of Bulk Substance batch release; in which case the original subcontractor batch number shall be retained in Sanofi’s batch release documentation and electronic inventory management system for ease of traceability. Batch numbers from each of Sanofi and its subcontractor will be provided to KaloBios. [***] CONFIDENTIAL PORTIONS OF THIS DOCUMENT REDACTED AND SEPARATELY FILED WITH THE COMMISSION.
Batch Numbering shall use the GNE batch numbering system for all GMP Product produced by SurModics.
Batch Numbering. ELITE batch numbering system will be used to uniquely number each batch of Product(s). This number will appear on all documents relating to a particular batch of Product(s).
Batch Numbering. Seller’s batch numbering system will be used for numbering each batch of each of the Products made for sale in the Territory. This identification will appear on all documents relating to the particular batch of the Products. To the extent commercially practicable, the code for batch numbering identification will be supplied to Purchaser.
Batch Numbering. Matricel’s batch numbering system will be used for numbering each batch of the ACI-Maix-Membrane Products made for sale. This identification will appear on all documents relating to the particular batch of the ACI-Maix-Membrane Products. The code for batch numbering identification will be supplied to Vericel.
Batch Numbering. 1.3.1. Ash Sxxxxxx will assign unique batch numbers for the Product in accordance with Ash Sxxxxxx Standard Operating Procedures (SOPs).
Batch Numbering. CBSI will assign batch numbers for the Drug Substance upon completion of and prior to delivery to Centocor in accordance with SOPs. /s/ MPR JCS /s/ VBL ------------- --------- JCS VBL Confidential Treatment Requested THE REGISTRANT HAS REQUESTED CONFIDENTIAL TREATMENT FOR CERTAIN PORTIONS OF THIS AGREEMENT. THOSE PORTIONS HAVE BEEN OMITTED FROM THIS COPY OF THE AGREEMENT AT THE PLACES INDICATED BY (XXXX); AND HAVE BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION 2.4 Processing responsibilities. CBSI will Manufacture and inspect the Drug Substance in strict accordance with cGMP, as set forth in 21 CER 211, as amended and updated from time to time, as well as the HPB Guide to GMP, and all other appropriate Regulatory Requirements.
Batch Numbering. Each batch of the Product manufactured by APP will bear a unique lot number using APP's batch numbering system. This number will appear on all documents relating to the particular batch of Product and shall identify the date of manufacture for the batch of Product.
Batch Numbering. Matricel’s batch numbering system will be used for numbering each batch of the ACI-Maix-Membrane Products made for sale. This identification will appear on all documents relating to the particular batch of the ACI-Maix-Membrane Products. The code for batch numbering identification will be supplied to Vericel. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
